These data further implicate circadian clock disruption in obesity and associated metabolic disturbance, and suggest that targeting of the clock represents a therapeutic avenue for the treatment of metabolic disorders. The gene discussed is CLOCK; the disease is obesity due to melanocortin 4 receptor deficiency.